insights_auto
M1RN34 neden yükseldi? 2,79%?
Daha Ayrıntılı Bilgichevron_right
M1RN34:BVMF
Moderna Inc Bdr
R$59,00
arrow_upward
+2,79%(+1,60) 1G
19 Kas, 18:07:00 GMT-3 · BRL
search
Tüm semboller
| Sembol | Fiyat | Değişiklik | Değişiklik % |
|---|
insights_autoM1RN34 ile ilgili en önemli analizler oluşturuluyor...
Açık
R$58,21
Yüksek
R$60,51
Düşük
R$56,30
Piy. değ.
78,90 Mr
Ort. hacim
171,48 B
İşlem Hacmi
0,00
52 haftalık en yüksek
R$77,25
52 haftalık en düşük
R$6,02
Tedavüldeki hisse senedi sayısı
404,62 Mn
Çalışan sayısı
5 B
Açık
R$58,21
Yüksek
R$60,51
Düşük
R$56,30
Piy. değ.
78,90 Mr
Ort. hacim
171,48 B
İşlem Hacmi
0,00
52 haftalık en yüksek
R$77,25
52 haftalık en düşük
R$6,02
Tedavüldeki hisse senedi sayısı
404,62 Mn
Çalışan sayısı
5 B
Haberler
Web kaynaklarından ve haber iş ortaklarından
Trefis
·
1 gün önce
What A Cancer Vaccine Stumble Means For Moderna Stock
Yahoo Finance
·
1 gün önce
Moderna: Can the Vaccine Business Fund Its Next Phase of Growth?
Investing.com
·
2 gün önce
Moderna president Stephen Hoge sells $16.9M in stock
The Globe and Mail
·
2 gün önce
Moderna's Cancer Vaccine Worked -- and the Stock Plunged Anyway. Here's What Investors Are Missing.
Profil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Moderna Inc Bdr hakkında
CEOStéphane Bancel
Çalışan Sayısı4,7 B
Kuruluş TarihiEyl 2010
Genel Merkez-
SektörHealth Care
Sektör-
Web Sitesimodernatx.com